Five things for pharma marketers to know: Monday, August 28, 2017

Gilead to acquire Kite; the FDA issues fewest number of warning letters since 2008; the regulator approves BI's Humira biosimilar

from Most popular articles from Medical Marketing and Media http://ift.tt/2wDWrYA